Skip to content

A study to find out whether Viscum album helps in reducing urine protein levels in patients with high blood pressure

Assessing the effectiveness of Viscum album in the treatment of A2 albuminuria in Essential Hypertension A quasi experimental study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102831
Enrollment
40
Registered
2026-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R809- Proteinuria, unspecified

Interventions

Intervention1: Viscum album: 1 Viscum album will be prescribed to all the patients having A2 albuminuria with Essential Hypertension 2 The selection of potency dosage and frequency of administration

Sponsors

Government Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are willing to participate voluntarily in the study and ready to sign the written informed consent will be enrolled Subjects aged 35 to 60 years of age will be selected Subjects with known case of Essential Hypertension Subjects with A2 Albuminuria with UACR levels between 30 to 300 milligrams of urine albumin per gram of urine creatinine

Exclusion criteria

Exclusion criteria: Subjects who are under any other medications for hypertension Subjects with known case of Diabetes mellitus Subjects with Secondary Hypertension Subjects with history of recent infection Pregnant or lactating mother

Design outcomes

Primary

MeasureTime frame
Primary outcome will be assessed based on the changes in the levels of UACR urinary albumin creatinine ratio from baseline to the end of follow up period of 6 monthsTimepoint: 1 The follow up will be done once in 15 days for the first 3 months and once in a month for the next 3 months 2 UACR will be done on the first visit to determine the baseline score and then repeated once in 3 months to assess the changes after intervention

Secondary

MeasureTime frame
Secondary outcome will be assessed based on the changes in systolic and diastolic blood pressure levels measured from baseline to each follow up visitTimepoint: Blood pressure will be checked once in 15 days for the first 3 months and once in a month for the next 3 months

Countries

India

Contacts

Public ContactDr Vani N

Government Homoeopathic Medical College and Hospital

drveeru9@gmail.com9844576674

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026